European Journal of Heart Failure
Effectiveness of Finerenone in Slowing Chronic Kidney Disease Progression After Hospitalization for Heart Failure: A FIDELITY Subgroup Analysis
Randomised trial in peopleFinerenone
Papers by Gerasimos Filippatos
12 results
- ESC Heart Failure
Neutrophil-to-Lymphocyte Ratio in Patients With Heart Failure: Findings From The EMPEROR Program
Trial in peopleBiomarkers - Journal of Cardiac Failure
The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 Diabetes
Randomised trial in 11,950 peopleFinerenone
- Journal of Cardiac Failure
Impact of Empagliflozin on Serum Calcium and Phosphate in Heart Failure
Randomised trial in 9,718 peopleEmpagliflozin - ADA Scientific Sessions 2026 Abstract
Inflammation, Body Mass Index, and Cardiovascular Outcomes in Chronic Kidney Disease and Type 2 Diabetes
Trial in peopleBiomarkers - AHA Scientific Sessions 2025 Abstract
Finerenone Reduces Loop Diuretic Requirement in Patients with Type 2 Diabetes and CKD: Participant-Level Pooled Analysis of FIDELIO-DKD and FIGARO-DKD
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk: Insights from the FIDELITY Program
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Estimated Lifetime Benefits of Finerenone on Cardiorenal Morbidity and Mortality in Patients with Type 2 Diabetes and Chronic Kidney Disease
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Major Adverse Cardiovascular Events across the Spectrum of Cardio-Kidney-Metabolic Syndrome: A FINE-HEART Pooled Analysis
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Finerenone Reduces Sudden Death across the Spectrum of Cardio-Kidney-Metabolism: the FINE-HEART Pooled Analysis
Trial in peopleInterventions